Microsoft Word - 150423_2_Eg.doc

April 23, 2015

Astellas Nominates Director and Audit & Supervisory Board Member

Tokyo, Japan, April 23, 2015 - Astellas Pharma Inc. (Headquarters: Tokyo; President and CEO: Yoshihiko Hatanaka) announced that, at a meeting of its Board of Directors held today, it decided on the following candidates for Director and Audit & Supervisory Board Member to be newly elected at the Ordinary General Meeting of Shareholders scheduled for June 17, 2015.

[Candidate of Director]

Outside Director Yoshiharu Aizawa

[Director to be retired]

Outside Director Naoki Aikawa

[Candidate of Audit & Supervisory Board Member]

Outside Audit & Supervisory Board Member Hitoshi Kanamori

[The Board of Directors and the Audit & Supervisory Board as from June 17, 2015 (planned)]

Board of Directors
Masafumi Nogimori (Representative Director and Chairman)
Yoshihiko Hatanaka (Representative Director, President and Chief Executive Officer) Yoshirou Miyokawa (Representative Director, Executive Vice President and Chief
Administrative Officer & Chief Compliance Officer) Yutaka Kase (Outside Director)
Hironobu Yasuda (Outside Director) Etsuko Okajima (Outside Director) Yoshiharu Aizawa (Outside Director)
Audit & Supervisory Board
Go Otani (Audit & Supervisory Board Member)
Tomokazu Fujisawa (Audit & Supervisory Board Member)
Shigeru Nishiyama (Outside Audit & Supervisory Board Member) Toshiko Oka (Outside Audit & Supervisory Board Member) Hitoshi Kanamori (Outside Audit & Supervisory Board Member)

#######

Contacts for inquiries or additional information

Astellas Pharma Inc. Corporate Communications

Tel: +81-3-3244-3201 Fax: +81-3-5201-7473 http://www.astellas.com/en/


distributed by